Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals IncorporatedVertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

No trades
See on Supercharts

VRTX fundamentals

Vertex Pharmaceuticals Incorporated key financial stats and ratios

VRTX price-to-sales ratio is 10.63. The company has an Enterprise Value to EBITDA ratio of 23.36. As of 2023 they employed 5.40 k people.

Statistics
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios